Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric Rheumatology International Trials Organization criteria for inactive disease and the myositis disease activity assessment tool-Reference-Cited by-同舟云学术

Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric Rheumatology International Trials Organization criteria for inactive disease and the myositis disease activity assessment tool

Published:2014-03-31 Issue:9 Volume:53 Page:1578-1585
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:Rheumatology

Author:

Sanner H.,Sjaastad I.,Flato B.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/53/9/1578/5299803/keu146.pdf

Reference30 articles.

1. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood

2. Long-term outcome and prognostic factors of juvenile dermatomyositis: A multinational, multicenter study of 490 patients

3. Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index

4. Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset

5. Long-term outcome in patients with juvenile dermatomyositis: a cross-sectional follow-up study

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Control of dermatomyositis skin disease activity lags behind control of muscles disease activity during the early treatment stages of classic dermatomyositis: A retrospective, single‐centre study;Skin Health and Disease;2024-03-14

2. Disease activity trajectories in juvenile dermatomyositis from childhood to adulthood;Rheumatology;2024-01-12

3. Advances in the diagnostics and treatment of juvenile dermatomyositis;Zeitschrift für Rheumatologie;2023-12-29

4. Efficacy and safety of repository corticotropin injection for refractory cutaneous dermatomyositis: a prospective, open-label study;Rheumatology;2023-11-06

5. Biologic drugs in the treatment of juvenile dermatomyositis: a literature review;Clinical Rheumatology;2023-08-16